Dermatological effects from years in the sun: Compounding opportunities

International Journal of Pharmaceutical Compounding

Volumn 10, Issue 5, 2006, Pages 336-342

  Jones, Marty ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 INDOLEMETHANOL; 4 METHOXYCINNAMIC ACID 2 ETHYLHEXYL ESTER; ALPHA2 INTERFERON; AMINOLEVULINIC ACID; ANTINEOPLASTIC AGENT; CALCIUM DERIVATIVE; CALCIUM DEXTRO GLUCURATE; DICLOFENAC; DIINDOLYLMETHANE; EDETATE DISODIUM; EPIGALLOCATECHIN GALLATE; EUXYL K 400; FLAVONOID; FLUOROURACIL; GLYCEROL; IMIQUIMOD; ISOTRETINOIN; LACTIC ACID; LEVULAN KERASTIK; METHANE; PERFUME; POLYPHENOL; POLYSORBATE 20; RECOMBINANT INTERLEUKIN 2; RESORCINOL; RETINOIC ACID; SALICYLIC ACID; SUNSCREEN; UNCLASSIFIED DRUG; UNINDEXED DRUG; UREA; XANTHAN;

ACTINIC KERATOSIS; ANTIOXIDANT ACTIVITY; BASAL CELL CARCINOMA; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CANCER STAGING; CANCER SURGERY; DISEASE COURSE; DRUG FORMULATION; DRUG MECHANISM; HUMAN; MELANOMA; NUTRITIONAL SUPPORT; PARSLEY; PHOTODYNAMIC THERAPY; REVIEW; SKIN BIOPSY; SKIN CANCER; SKIN DEFECT; SQUAMOUS CELL CARCINOMA; SUN EXPOSURE; SUNLIGHT;

EID: 33748759845     PISSN: 10924221     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (28)

1. May HG, Metzger B, eds. The Oxford Annotated Bible with the Apocrypha. New York, NY: Oxford University Press; 1965:1-2.
2. [No author listed.] Gateways to Babylon. Utu (Shamash): The Sun Lord. [Gateways to Babylon Website.] Available at: www.gatewaystobabylon.com/gods/ lords/lordutu.html. Accessed April 15, 2006.
3. Moseley H, Davidson M, Ferguson J. A hazard assessment of artificial tanning units. Photodermatol Photoimmunol Photomed 1998; 14(2): 79-87.
4. Walter SD, Marrett LD, From L et al. The association of cutaneous melanoma with the use of sunbeds and sunlamps. Am J Epidemiol 1990; 131(2): 232-243.
5. Kozmin S, Slezak G, Reynaud-Angelin A et al. UVA radiation is highly mutagenic in cells that are unable to repair 7,8-dihydro-8-oxoguanine in Saccharomyces cerevisiae. Proc Natl Acad Sci USA 2005; 102(38): 13538-13543.
6. Gallagher RP, Spinelli JJ, Lee TK. Tanning beds, sunlamps, and risk of cutaneous malignant melanoma. Cancer Epidemiol Biomarkers Prev 2005; 14(3): 562-566.
7. [No author listed.] Skin Cancer. [A. P. John Institute for Cancer Research Website.] Available at: www.apjohncancerinstitute.org/cancer/skin.htm. Accessed April 25, 2006.
8. Mackie RM. Long-term health risk to the skin of ultraviolet radiation. Prog Biophys Mol Biol 2005; 92(1): 92-96.
9. Robinson JK, Turrisi R. Skills training to learn discrimination of ABCDE criteria by those at risk of developing melanoma. Arch Dermatol 2006; 142(4): 447-452.
10. Geller AC, Brooks DR, Colditz GA et al. Sun protection practices among offspring of women with personal or family history of skin cancer. Pediatrics 2006; 117(4): e688-e694.
11. [No author listed.] eMaxHealth. Cancer Treatment: Skin Cancer, Symptoms of Skin Cancer, Treatment of Melanoma. [eMaxhealth Website.] Available at: www.emaxhealth.com. Accessed April 28, 2006.
12. [No author listed.] AAD Pamphlet. Skin Cancer. [American Academy of Dermatology Website.] Available at: www.aad.org. Accessed April 15, 2006.
13. Buckel TB, Goldstein AM, Fraser MC et al. Recent tanning bed use: A risk factor for melanoma. Arch Dermatol 2006; 142(4): 485-488.
14. Hanson RP, Kneafsey B, Royston D. Cutaneous lesions, not just skin deep! Ir J Med Sci 2006; 175(1): 66-68.
15. Huang MT, Ho CT, Wang ZY et al. Inhibitory effect of topical application of a green tea polyphenol fraction on tumor initiation and promotion in mouse skin. Carcinogenesis 1992; 13(6): 947-954.
16. Katiyar SK, Afaq F, Perez A et al. Green tea polyphenol (-)-epigallocatechin-3-gallate treatment of human skin inhibits ultraviolet radiation-induced oxidative stress. Carcinogenesis 2001; 22(2): 287-294.
17. Hinneburg I, Kempe S, Ruttinger HH et al. Antioxidant and photoprotective properties of an extract from buckwheat herb (Fagopyrum esculentum MOENCH). Pharmazie 2006; 61(3): 237-240.
18. Murray MT. Encyclopedia of Nutritional Supplements. Blaine, MN: Prima Publishing; 1996: 220-326.
19. Yu TC, Rahman Z, Ross BS. Actinic keratoses-Surgical and physical therapeutic modalities. Cutis 2003; 71(5): 381-384.
20. Rivers JK, Arlette J, Shear N et al. Topical treatment of actinic keratoses with 3.0% diclofenac in 2.5% hyaluronan gel. Br J Dermatol 2002; 146(1): 94-100.
21. Presaud AN, Shamuelova E, Sherer D et al. Clinical effect of imiquimod 5% cream in the treatment of actinic keratoses. J Am Acad Dermatol 2002; 47(4): 553-556.
22. McGillis ST, Fein H. Topical treatment strategies for non-melanoma skin cancer and precursor lesions. Semin Cutan Med Surg 2004; 23(3): 174-183.
23. Soler AM, Angell-Petersen E, Warloe T et al. Photodynamic therapy of superficial basal cell carcinoma with 5-aminolevulinic acid with dimethylsulfoxide and ethylendiaminetetraacetic acid: A comparison of two light sources. Photochem Photobiol 2000; 71(6): 724-729.
24. Kuijpers DI, Thissen MR, Neumann MH. Basal cell carcinoma: Treatment options and prognosis, a scientific approach to a common malignancy. Am J Clin Dermatol 2002; 3(4): 247-259.
25. Shumack S, Robinson J, Kossard S et al. Efficacy of topical 5% imiquimod cream for the treatment of nodular basal cell carcinoma: Comparison of dosing regimens. Arch Dermatol 2002; 138(9): 1165-1171.
26. Malik Z, Kostenich G, Roitman L et al. Topical application of 5-aminolevulinic acid, DMSO and EDTA: Protoporphyrin IX accumulation in skin and tumours of mice. J Photochem Photobiol B 1995; 28(3): 213-218.
27. Lippman SM, Parkinson DR, Itri LM et al. 13-cis-retinoic acid and interferon alpha-2a: Effective combination therapy for advanced squamous cell carcinoma of the skin. J Natl Cancer Inst 1992; 84(4): 235-241.
28. [No author listed.] Chiron. Proleukin IL-2 (aldesleukin) for Injection Therapy. [Chiron Website.] Available at: www.proleukin.com. Accessed April 28, 2006.